Adma Biologics (ADMA) EBITDA (2007 - 2026)
Adma Biologics (ADMA) EBITDA from Jun 30, 2007 to Mar 31, 2026. The TTM Adma Biologics (ADMA) EBITDA is $223M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Adma Biologics (ADMA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +39.43% |
Annual EBITDA change of Adma Biologics (ADMA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $60M | -69.88% |
| 2025 | $199M | +35.97% |
| 2024 | $147M | +401.81% |
| 2023 | $29M | -188.66% |
| 2022 | -$33M | -38.45% |
| 2021 | -$54M | -13.19% |
| 2020 | -$62M | +58.15% |
| 2019 | -$39M | -32.36% |
| 2018 | -$58M | +52.58% |
| 2017 | -$38M | +123.33% |
| 2016 | -$17M | +12.57% |
| 2015 | -$15M | -4.63% |
| 2014 | -$16M | +6.34% |
| 2013 | -$15M | +91.85% |
| 2012 | -$7.73M | +75.68% |
| 2011 | -$4.40M | +14566.67% |
| 2010 | -$30K | +50.00% |
| 2009 | -$20K | N/A |
| 2008 | -$20K | -33.33% |
| 2007 | -$30K | N/A |